News

Immuno-PET predicts patient response to rituximab therapy

View more

Mar 10, 2023

QSAM Biosciences Completes Enrollment of Initial Cohort in its Phase 1 Study of CycloSam® Targeting Metastatic Bone Cancer

View more

Mar 10, 2023

NorthStar Receives Electron Beam Accelerator for First-of-its-Kind, Commercial-scale U.S. Production of Important Therapeutic Radioisotope Actinium-225 (Ac-225)

View more

Mar 10, 2023

FAPI-PET shows promise in patients with RA

View more

Mar 10, 2023

Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy

View more

Mar 10, 2023

PET AI model improves lung cancer staging

View more

Mar 03, 2023